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  The transient receptor potential melastatin type 7 (TRPM7) channel is a widely expressed non- 
selective cation channel with fusion to the C-terminal alpha kinase domain and regarded as a key 
regulator of whole body Mg2+ homeostasis in mammals. However, the roles of TRPM7 during osteoclast-
ogenesis in RAW264.7 cells and bone marrow-derived monocyte/macrophage precursor cells (BMMs) 
are not clear. In the present study, we investigate the roles of TRPM7 in osteoclastogenesis using 
methods of small interfering RNA (siRNA), RT-PCR, patch-clamp, and calcium imaging. RANKL 
(receptor activator of NF-κB ligand) stimulation did not affect the TRPM7 expression and 
TRPM7-mediated current was activated in HEK293, RAW264.7, and BMM cells by the regulation of 
Mg2+. Knock-down of TRPM7 by siTRPM7 reduced intracellular Ca2+ concentration ([Ca2+]i) increases 
by 0 mM [Mg2+]e in HEK293 cells and inhibited the generation of RANKL-induced Ca2+ oscillations 
in RAW264.7 cells. Finally, knock-down of TRPM7 suppressed RANKL-mediated osteoclastogenesis 
such as activation and translocation of NFATc1, formation of multinucleated cells, and the bone 
resorptive activity, sequentially. These results suggest that TRPM7 plays an essential role in the 
RANKL-induced [Ca2+]i oscillations that triggers the late stages of osteoclastogenesis.
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INTRODUCTION
  Calcium (Ca2+) plays a critical role in many cellular proc-
esses from differentiation to death in cells. Ca2+ entry into 
cells mediates by store-operated Ca2+ channels (SOCs) and 
transient receptor potential (TRP) channels [1]. TRP chan-
nels have been proposed to operate as SOCs. TRP channels 
consist of six transmembrane spanning domains (S1-6) with 
a pore-forming loop between S5 and S6, and include intra-
cellular N- and C-terminal regions. According to the degree 
of amino acid homology, the TRP family can be subdivided 
into seven subgroups (TRPC, TRPV, TRPM, TRPA, TRPP, 
TRPML, and TRPN). TRPM (M stands for “melastin”) be-
longs to super-family of TRP channels, which consist of 
eight different isoforms, TRPM1-TRPM8 [2]. Apart from 
other TRP channels, the distinct characteristic of TRPM 
does not contain N-terminal ankyrin repeat motifs but con-
tain functional proteins in C-termini. TRPM7, for example, 
contain functional α-kinase segments, a type of ser-
ine/threonine-specific protein kinase [3,4] that is essential 
for modulating channel activity [5,6]. Due to its structural 
features, TRPM7 is considered as both a kinase, which is 
capable of phosphorylating itself and other substrates, and 
a cation channel, which conducts cations (highly permeable 
to Ca2+ and Mg2+) into the cell [7]. TRPM7, as a cation chan-
nel, is constitutively opened and mediates capacitative Ca2+ 
entry, which is tightly regulated by intracellular Mg2+ con-
centration such as Mg-ATP and other Mg-nucleotides [8].
  RANKL (receptor activator of nuclear factor-κB ligand) 
is expressed in osteoblastic/stromal cells and is critical im-
portance for osteoclast differentiation. In our previous works, 
it has been reported that RANKL-induced oscillations by in-
tracellular Ca2+ concentration ([Ca2+]i) increases are related 
with the extracellular Ca2+ influx through SERCA (sarco/ 
endoplasmic reticulum Ca2+ ATPase) and SOCs, and intra-
cellular ROS (reactive oxygen species) increases [9,10]. Ex-
tracellular Ca2+ influx for maintaining [Ca2+]i oscillations 
trigger the late stage in osteoclast differentiation [11]. How-
ever, Ca2+ entry pathway via the plasma membrane in oste-
oclastogenesis is not clearly known. The activity of TRPM7, 
as a Ca2+ permeable cation channel, is indispensable part 
of maintaining cell homeostasis including cell growth, pro-
liferation and differentiation [4]. TRPM7 also can be acti-
vated by ROS and regulated intracellular Mg2+ level 
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[12,13]. It was suggested that TRPM7 can serve as a Ca2+ 
permeable cation channel in osteoclasts and regulate the 
activity of the RANKL-induced Ca2+ oscillations and osteo-
clastogenesis.
  In this study, we aimed to investigate the involvement 
of TRPM7 in RANKL-induced Ca2+ oscillations as a Ca2+ 
permeable channel and the role in physiological activities 
of osteoclasts.
METHODS
Cell culture and reagents
  RAW264.7 (Korean Cell Line Bank, South Korea) and 
primary cultured BMMs were maintained in Dulbecco's 
modified Eagle’s medium (DMEM, Invitrogen, Carlsbad, 
CA, USA) and minimum essential medium alpha (α-MEM) 
supplemented with 10% fetal bovine serum (FBS, Invitro-
gen) and incubated in 5% CO2 incubator. M-CSF and 
RANKL were treated at 50 ng/ml concentration in α-MEM. 
RANKL and M-CSF were purchased from KOMA Biotech 
(Seoul, Korea). HEK293 cells were cultured in DMEM con-
taining 10% FBS, and 100 units/ml penicillin and strepto-
mycin. Fura-2/AM was purchased from Teflabs (Austin, TX, 
USA). Gadolinium chloride (Gd3+) and adenosine triphos-
phate (ATP) were from Sigma Aldrich (St Louis, MO, USA). 
Monoclonal antibody (mAbs) for NFATc1 and polyclonal an-
tibody for TRPM7 were obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA, USA).
Preparation of BMMs 
  The femur and tibia were isolated from 4∼6 weeks old 
mice as described previously [14]. Whole cells derived from 
bone marrow of femur and tibia was collected and cultured 
in α-MEM medium containing 10% FBS and 10 ng/ml 
M-CSF. The following day, non-adherent cells in media 
were collected and seeded on adequate plates and treated 
with M-CSF (50 ng/ml). After 2 days non-adherent cells 
were washed out and adherent cells were used as BMMs.
RT-PCR (reverse transcription polymerase chain reaction)
  Total RNA was isolated from each cell using Trizol re-
agents (Invitrogen). Total isolated RNA was amplified ac-
cording to the manufature’s protocol using AccuPowerⓇ RT 
PreMix (BIONEER, Daejeon, Korea). cDNA was amplified 
by PCR with HiPiTM Thermostable DNA polymerase (Elpis, 
Seoul, Korea). The primer sequences of genes were as fol-
lows: TRPM7 (531 bp), 5'-AGG AGA ATG TCC CAG AAA 
TCC-3' (forward) and 5'-TCC TCC AGT TAA AAT CCA 
AGC-3' (reverse); β-actin (514 bp), 5'-TGT GAT GGT GGG 
AAT GGG TCA G-3' (forward) and 5'-TTT GAT GTC ACG 
CAC GAT TTC C-3' (reverse).
siRNA transfection
  Small interfering (si) RNA for TRPM7, sense (5'-ACC 
GAG CTG GTC GCA CAA TTA TTT CAA GAG AAT AAT 
TGT GCG ACC AGC TCT TTT TC-3') and anti-sense 
(5'-TGC AGA AAA AGA GCT GGT CGC ACA ATT ATT 
CTC TTG AAA TAA TTG TGC GAC CAG CT-3'), was an-
nealed with T4 DNA ligase and inserted into 50 ng/μl psi- 
STRIKE vector (Promega Corporation, Madison, WI, USA) 
by following the manufacture’s procedure. Cells were seed-
ed on 35 mm dish at a density of 1∼5×105 cells in anti-
biotics free media. After 24 h, cells were re-plated in ad-
equate dish. Each plasmid and Lipofectamine 2000 (Invitro-
gen) was diluted in 250μl Opti-MEM respectively and then 
mixed. The mixture was incubated for 20 min at room tem-
perature before adding the cell media. Cells were assorted 
with pEGFP expression.
Western blot
  Whole cell lysates were prepared using RIPA lysis buffer 
(20 mM Tris, pH 7.4, 250 mM NaCl, 2 mM EDTA, pH 8.0, 
0.1% Triton-×100, 0.01 mg/ml aprotinin, 5 μg/ml leupeptin, 
0.4 mM PMSF, and 4 mM NaVO4), and then spun at 12,000 
rpm for 10 min to remove insoluble material. Proteins (50∼
100 μg/well) were subjected to 6∼12% SDS-PAGE respec-
tively, and then were separated by size. Separated proteins 
were electro-transferred to a nitrocellulose membrane, blo-
cked with 6% skimmed milk, and probed with Abs against 
TRPM7 (1：1,000) and NFATc1 (1：3,000). Thereafter, 
blots were washed, exposed to horseradish peroxidase-con-
jugated secondary antibodies for 1 h, and finally detected 
by chemiluminescence (Amersham Pharmacia Biotech, 
Alington Heights, IL, USA).
[Ca2+]i measurement
  Cells were seeded on cover glass in 35-mm dishes (5×104 
cells). After 24 h, cells were stimulated with RANKL (50 
ng/ml) for indicated time. Cells in physiological salt solution 
(140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 
mM HEPES, 10 mM glucose, 310 mOsm, pH 7.4) were in-
cubated with 5 μM Fura-2/AM 0.05% Pluronic F-127 for 
30 min at room temperature and washed out with bath 
solution. The adherent cells on cover glass were placed on 
the bottom of a perfusion chamber, and bath solution was 
perfused continuously. Fura-2 fluorescence intensity was 
measured using excitation wave lengths of 340 and 380 nm, 
and emitted fluorescence 510 nm (Ratio=F340/F380) was col-
lected and monitored at 2 s intervals using a CCD camera 
(Universal Imaging Co., Downingtown, PA, USA) as de-
scribed previously [15]. Images were digitized and analyzed 
through MetaFluor software (Universal Imaging).
Electrophysiology
  Whole-cell voltage-clamp recordings were made using the 
perforated patch-clamp method at room temperature. Cur-
rents were recorded using a MultiClamp 700B amplifier 
(Axon Instruments, Union City, CA, USA), subsequently 
digitized with a sampling rate of 10 kHz, and analyzed us-
ing pCLAMP10 software (Axon Instruments). The pipette 
resistance varied between 3∼5 MΩ. Whole-cell currents 
were elicited by voltage ramps from －100 mV to ＋100 mV 
(50-ms duration) applied every 2 s from a holding potential 
of 0 mV. Pipettes for recordings of TRPM7 currents were 
filled with an internal solution containing (in mM): 140 
CsCl, 8 NaCl, 10 EGTA, 10 HEPES, adjusted to pH 7.2 
with CsOH [16]. Nystatin was diluted to a final concen-
tration of 250μg/ml in the internal solution. The external 
solution containing (in mM): 140 NaCl, 3 KCl, 1 CaCl2, 2 
MgCl2, 10 HEPES, 10 glucose, adjusted to pH 7.2 with 
NaOH, and the external solution was replaced by 3 mM 
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Fig. 1. Expression of and activation of endogenous TRPM7 channels in HEK293, RAW264.7, and BMMs. (A) Whole cells lysates were collected 
from cells stimulated with RANKL for indicated time. TRPM7 was blotted with its antibody. (B) mRNA expression of TRPM7 were decreased 
after transfection of siTRPM7 in HEK293 and RAW264.7 cells. (C) Activation of endogenous TRPM7-mediated currents by a voltage ramp 
(－100 mV to ＋100 mV in 50-ms intervals, Vh=0 mV), used to determine current-voltage relations in cells. TRPM7 currents were activated 
by 0 mM [Mg2＋]e and these effects diminished in TRPM7 knock-down cells. (D) The amplitude of endogenous TRPM7-mediated currents 
at －80 and ＋80 mV in HEK293 and RAW264.7 cells. Data were expressed as the mean±SEM. **p＜0.01, *p＜0.05 compared with control.
CaCl2 to change a Mg2+-free external solution.
Immunocytochemistry
  Cells were seeded on coverslips (22×22) and treated with 
50 ng/ml RANKL for 48 h. After fixation in 4% paraf-
ormaldehyde (PFA) for 5 min, cells were sequentially in-
cubated in blocking solution (0.1% gelatin, 1% BSA, 0.01% 
sodium azide, 5% goat serum) for 30 min, overnight in 
blocking solution containing Abs against NFATc1 (1：100), 
and finally were treated with Alexa 488-labeled anti-mouse 
IgG antibody (Molecular Probes) in blocking solution for 1 h. 
Nuclei was separately stained with DAPI.
TRAP staining
  The method of TRAP staining has been detailed pre-
viously [10]. Briefly, cells were seeded on 48 well-plate at 
a density of 2×104 cells/well and cultured in α-MEM con-
taining 10% FBS with 50 ng/ml RANKL and M-CSF. After 
6 days, TRAP (tartrate-resistant acid phosphatase) staining 
was performed to determine the extent of differentiation. 
Cytochemical staining of TRAP+ cells were performed using 
the Leukocyte Acid Phosphate Assay Kit (Sigma Aldrich) 
by following the manufacturer's procedure. TRAP+ multi-
nucleated cells (MNCs, ≥3 nuclei) were counted.
Pit assay
  Cells were seeded on bone-slice covered plates (OAAS) 
and maintained with 50 ng/ml M-CSF and sRANKL for 15 
days. After that, cells were washed with sodium hypochlor-
ite solution for 1 h at room temperature. Bone slices were 
imaged, and pits were calculated using MetaMorph soft-
ware (Molecular Devices).
Statistics
  All data were expressed as the mean±SEM. Statistical 
significance was determined by using a paired or unpaired 
Student’s t-test. Statistical significance was set at p＜0.05 
level.
RESULTS
Expression and actions of endogenous TRPM7 channels
  TRPM7 has been identified as spontaneously activated 
Ca2+- and Mg2+-entry channels and plays a key role for os-
teoblasts proliferation [17]. In this study, we first examined 
whether RANKL stimulation affects on the expression of 
TRPM7. In order to confirm the expression of TRPM7, 
RANKL was respectively treated for 6 days that is pre-
dicted time to be differentiated into osteoclast. As shown 
in Fig. 1A, the expression of TRPM7 in RAW264.7 cells was 
not altered in the presence of RANKL. mRNA expressions 
of TRPM7 were reduced in siTRPM7-tranfected cells (Fig. 
1B). In whole-cell patch-clamp experiments, the removal of 
Mg2+ in extracellular solutions led to activation of TRPM7- 
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Fig. 2. Effects of deletion of TRPM7 on [Ca2+]i increases mediated by RANKL stimulation and removal of extracellular Mg2+. (A) Cells were 
transfected with siTRPM7 using lipofectamine 2000. After 72 h of transfection, whole mRNA was collected using Trizol method. Beta-actin 
is used as loading control. (B) Control and siTRPM7 treated cells were treated with RANKL. After 48 h of RANKL stimulation, [Ca2+]i in 
single cell was measured using Fura-2 fluorescence dye. To confirm cell’s viability, 1 mM ATP was used. (C) Application of 0 mM [Mg2+]e induced 
[Ca2+]i increases and it was repeated by the second application of 0 mM [Mg2+]e in HEK293 cells. [Ca2+]i increases also inhibited by 100 μM 
Gd3+ and transfected siTRPM7. (D) Application of 0 mM [Mg2+]e induced [Ca2+]i increases in the absence or presence of RANKL and it was 
inhibited by 100 μM Gd3+ and transfected siTRPM7 in RAW264.7 cells. (E) The degree of [Ca2+]i increases by 0 mM [Mg2+]e in HEK293 and 
RAW264.7 cells. Data were expressed as the mean±SEM. ***p＜0.001 compared with 0 mM [Mg2+]e treated control. n.s., not significant.
mediated currents that exhibit a highly nonlinear cur-
rent-voltage (I-V) relationship with noticeable outward rec-
tification at positive potentials in eGFP-transfected cells 
but not showed these effects in siTRPM7-transfected cells 
(Fig. 1C and 1D). A strongly outward-rectifying I-V rela-
tionship of TRPM7 is very similar features to other pre-
vious reports and these results show that TRPM7 is ex-
pressed regardless of RANKL stimulation and activated by 
low-Mg2+ concentration [14,15,18].
Effects of deletion of TRPM7 on RANKL-induced Ca2+ 
signaling
  RANKL-induced Ca2+ increase, which is composed of inernal 
Ca2+ release and extracellular Ca2+ influx, is essential step 
for triggering late-stage of osteoclastogenesis by activating 
NFATc1 [9,10]. To confirm whether TRPM7 is involved in 
the induction of RANKL-induced Ca2+ oscillations as a Ca2+ 
permeable channel, we examined the effects of deletion of 
TRPM7 on Ca2+ responses in the presence or absence of 
RANKL. Reduced mRNA expression of TRPM7 by siTRPM7 
treatment (Fig. 2A) resulted in disappearance of Ca2+ oscil-
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Fig. 3. Effects of deletion of TRPM7 on NFATc1 and bone resorptive activity. (A and B) Cells were transfected with sicontrol and siTRPM7 
in the presence or absence of RANKL for 48 h. To confirm the localization and expression of NFATc1, cells were fixed with 4% paraformaldehyde 
(PFA) and whole lysates were collected using RIPA lysis buffer respectively. Localization inside the cell and NFATc1 expression in whole 
lysates was confirmed with antibody for NFATc1. (C) To verify the formation of MNCs, each sample was incubated for 6 days in the presence 
of RANKL. TRAP staining was performed as described in methods. And then MNCs in each well was counted. (D) To determine the bone 
resorptive activity, cells were seeded on bone-slice covered plate in the presence of RANKL for 15 days. After incubation, whole image of 
each well was taken to calculate mineralized area as described in methods. Data were normalized to the expression level in RANKL treated 
control and expressed as the mean±SEM. **p＜0.01, *p＜0.05 compared with RANKL treated control.
lations in response to RANKL stimulation (Fig. 2B), which 
indicates that activation of TRPM7 is related with the in-
duction of Ca2+ oscillations in osteoclastogenesis. We also 
observed that siTRPM7 inhibited Ca2+ signaling by 0 mM 
[Mg2+]e in the presence or absence of RANKL of RAW264.7 
cells (Fig. 2D and 2E). The generation of Ca2+ oscillations 
are related with Ca2+ entry and Ca2+ release from intra-
cellular IP3-sensitive Ca2+ stores, and Ca2+ entry is medi-
ated through the Mg2+-sensitive pathway in polarized cells 
[19,20]. In HEK293 cells, Ca2+ signaling by 0 mM [Mg2+]e 
was completely blocked by 100 μM Gd3+, a known blocker 
of Ca2+ release activated Ca2+ entry (Fig. 2C and 2E). 
Interestingly, the [Ca2+]i increases by Mg2+ free solution 
were not observed in TRPM7 knock-down cells. These re-
sults suggest that TRPM7 is playing an essential role in 
RANKL-induced Ca2+ oscillations as mediating an ex-
tracellular Ca2+ entry which is regulated through the 
Mg2+-sensitive pathway.
Effects of deletion of TRPM7 in late-stage of osteoclas-
togenesis
  It has been known that RANKL-induced Ca2+ oscillations 
is a key factor to determine the late-stage of osteoclasto-
genesis by sequentially activating calmodulin, calcineurin, 
and NFATc1 [11]. Activated NFATc1 gets translocated into 
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the nucleus and function as a transcription factor, which 
induces the expression of proteins such as TRAP, Src kin-
ase, INF-γ, calcitonin, etc [21]. Over these series of protein 
expression, precursor cells get fused into MNCs, which have 
abilities of mineralizing the bone. According to previous re-
sults, we hypothesized that abolished Ca2+ oscillations by 
deletion of TRPM7 would affect on the activities of bone 
resorption. To confirm our hypothesis, the expression and 
translocation of NFATc1 in response to deletion of TRPM7 
was examined in RAW264.7 cells and BMMs. As a result, 
lack of TRPM7 diminished RANKL-induced NFATc1 trans-
location into nucleus and reduced NFATc1 expression by 
60% in RAW264.7 cells (Fig. 3A) and BMMs (Fig. 3B). 
Furthermore, deletion of TRPM7 significantly reduced 
RANKL-induced responses, formation of MNCs in BMMs 
(Fig. 3C) and bone resorptive activity in RAW264.7 cells 
(Fig. 3D). Taken together, these results suggest that abol-
ished Ca2+ oscillations by deletion of TRPM7 affected on 
NFATc1 activities, fusion into MNCs, and bone resorption.
DISCUSSION
  As tools for communication, intracellular Ca2+ concen-
tration determine various cellular responses such as pro-
liferation, movement, differentiation, etc [1]. Two separated 
Ca2+ sources, internal and external Ca2+ sources, are vir-
tually being used for triggering and maintaining all the 
Ca2+ responses including osteoclastogenesis. The property 
as a Ca2+ conducting channels raised the possibility that 
TRPM7 may be involved in osteoclastogenesis, based on the 
requirement for Ca2+ responses. In present study, we exam-
ined the potential use of TRPM7 in modulating the bone 
resorptive activities of osteoclast. The first finding of this 
study is that TRPM7 is being expressed in osteoclast pre-
cursor cells and the constitutive activities are being neg-
atively regulated by intracellular Mg2+ concentration. In os-
teoclastogenesis, precursor cells present long-lasting Ca2+ 
oscillations in response to RANKL stimulation. Signals 
leading differentiation clearly require sustained extrace-
llular Ca2+ influx through certain Ca2+ permeable channels. 
Hence, our result suggests that TRPM7 must be considered 
as a candidate for mediating the long-lasting Ca2+ oscillations. 
Notably, RANKL-induced Ca2+ oscillations and extracellular 
Ca2+ influx mediated by reduction of intracellular Mg2+ con-
centration were completely diminished by deletion of TRPM7. 
In our previous work, ROS, which is generated by RANKL 
stimulations, induce Ca2+ oscillations through activating 
the enzymatic reaction such as PLC [9,22]. Based on its 
characteristics as a kinase and channel, our results strongly 
suggest that function of TRPM7 as a kinase and cation chan-
nel is tightly linked with RANKL-induced ROS generation. 
Taken together, constitutive expression of TRPM7 would 
help precursor cells immediately sense the ROS generation 
and then ROS mediated activation of TRPM7 contributes 
the induction of Ca2+ oscillations by allowing extracellular 
Ca2+ influx. In terms of Mg2+ homeostasis in blood plasma, 
it is well established that bone is also considered as Mg2+ 
store in a body. Negative regulation of TRPM7 by Mg2+ con-
centration may explain the regulation of osteoclast activa-
tion. Our present study strongly proposes that Mg2+ concen-
tration in blood plasma is one of determinants for osteoclast 
activity by modulating the TRPM7 conductance.
  It has been reported that NFATc1 expression is enhanced 
in response to RANKL stimulation at transcriptional level. 
Considering our main focus of this study, which is on identi-
fying the possibility as a candidate for modulating the bone 
metabolism, we investigated the effects of deletion of 
TRPM7 on late-stage of osteoclastogenesis like forming 
MNCs and bone resorption. Only if TRPM7 has roles in 
a process of being differentiated into fully-activated osteo-
clasts, we may use it as a target molecule to treat bone 
diseases. Our results indicate that extracellular Ca2+ influx 
through TRPM7 is regarded as a nodal point which sequen-
tially regulates in the activity of NFATc1, forming MNCs, 
and physiological activity of osteoclasts. These findings ad-
dress missing links between generation of ROS and in-
duction of Ca2+ oscillations, which are required for triggering 
late-stage of osteoclastogenesis. TRPM7, which is activated 
by sensing both intracellular ROS generation and ex-
tracellular Mg2+ concentration, is acting as a mediator of 
extracellular Ca2+ entry in RANKL-induced osteoclasto-
genesis. Based on our results, adjusting the activities of 
TRPM7 by genetic modification and Mg2+ ingestion has to 
be considered as a novel way to treat bone diseases. 
ACKNOWLEDGEMENTS
  This research was supported by the Basic Science Resear-
ch Program through the National Research Foundation of 
Korea (NRF) funded by the Ministry of Education, Science 
and Technology (MEST) (2012R1A2A1A01003487, 2012-00 
00802).
REFERENCES
1. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: 
dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol. 
2003;4:517-529.
2. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor 
potential cation channels in disease. Physiol Rev. 2007;87: 
165-217.
3. McNulty S, Fonfria E. The role of TRPM channels in cell death. 
Pflugers Arch. 2005;451:235-242. 
4. Kraft R, Harteneck C. The mammalian melastatin-related 
transient receptor potential cation channels: an overview. Pflu-
gers Arch. 2005;451:204-211.
5. Clark K, Middelbeek J, Lasonder E, Dulyaninova NG, Morrice 
NA, Ryazanov AG, Bresnick AR, Figdor CG, van Leeuwen FN. 
TRPM7 regulates myosin IIA filament stability and protein 
localization by heavy chain phosphorylation. J Mol Biol. 2008; 
378:790-803. 
6. Dorovkov MV, Ryazanov AG. Phosphorylation of annexin I by 
TRPM7 channel-kinase. J Biol Chem. 2004;279:50643-50646. 
7. Boesmans W, Owsianik G, Tack J, Voets T, Vanden Berghe P. 
TRP channels in neurogastroenterology: opportunities for the-
rapeutic intervention. Br J Pharmacol. 2011;162:18-37.
8. Paravicini TM, Chubanov V, Gudermann T. TRPM7: a unique 
channel involved in magnesium homeostasis. Int J Biochem 
Cell Biol. 2012;44:1381-1384.
9. Kim MS, Yang YM, Son A, Tian YS, Lee SI, Kang SW, Muallem 
S, Shin DM. RANKL-mediated reactive oxygen species path-
way that induces long lasting Ca2+ oscillations essential for 
osteoclastogenesis. J Biol Chem. 2010;285:6913-6921.
10. Yang YM, Kim MS, Son A, Hong JH, Kim KH, Seo JT, Lee 
SI, Shin DM. Alteration of RANKL-induced osteoclastogenesis 
in primary cultured osteoclasts from SERCA2＋/－ mice. J Bone 
Miner Res. 2009;24:1763-1769.
11. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida 
H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak 
TW, Kodama T, Taniguchi T. Induction and activation of the 
TRPM7 and RANKL-Induced Osteoclastogenesis 71
transcription factor NFATc1 (NFAT2) integrate RANKL signal-
ing in terminal differentiation of osteoclasts. Dev Cell. 2002;3: 
889-901.
12. Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski 
W, MacDonald JF, Tymianski M. A key role for TRPM7 
channels in anoxic neuronal death. Cell. 2003;115:863-877.
13. Su LT, Chen HC, González-Pagán O, Overton JD, Xie J, Yue 
L, Runnels LW. TRPM7 activates m-calpain by stress-depen-
dent stimulation of p38 MAPK and c-Jun N-terminal kinase. 
J Mol Biol. 2010;396:858-869. 
14. Son A, Kim MS, Jo H, Byun HM, Shin DM. Effects of inositol 
1,4,5-triphosphate on osteoclast differentiation in RANKL- 
induced osteoclastogenesis. Korean J Physiol Pharmacol. 2012; 
16:31-36. 
15. Park S, Lee SI, Shin DM. Role of regulators of g-protein signal-
ing 4 in ca signaling in mouse pancreatic acinar cells. Korean 
J Physiol Pharmacol. 2011;15:383-388. 
16. Demeuse P, Penner R, Fleig A. TRPM7 channel is regulated 
by magnesium nucleotides via its kinase domain. J Gen 
Physiol. 2006;127:421-434. 
17. Abed E, Moreau R. Importance of melastatin-like transient 
receptor potential 7 and cations (magnesium, calcium) in human 
osteoblast-like cell proliferation. Cell Prolif. 2007;40:849-865.
18. Kim BJ, Lim HH, Yang DK, Jun JY, Chang IY, Park CS, So 
I, Stanfield PR, Kim KW. Melastatin-type transient receptor 
potential channel 7 is required for intestinal pacemaking 
activity. Gastroenterology. 2005;129:1504-1517.
19. Yu WG, Sokabe M. Hypotonically induced whole-cell currents 
in A6 cells: relationship with cell volume and cytoplasmic Ca2+. 
Jpn J Physiol. 1997;47:553-565.
20. Jans D, De Weer P, Srinivas SP, Larivière E, Simaels J, Van 
Driessche W. Mg2+-sensitive non-capacitative basolateral Ca2+ 
entry secondary to cell swelling in the polarized renal A6 
epithelium. J Physiol. 2002;541:91-101.
21. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation 
and activation. Nature. 2003;423:337-342.
22. Runnels LW, Yue L, Clapham DE. The TRPM7 channel is 
inactivated by PIP(2) hydrolysis. Nat Cell Biol. 2002;4:329-336.
